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Deep brain stimulation (DBS) has been found to have therapeutic effects in patients with dementia, but DBS mechanisms remain
elusive. To provide evidence for the effectiveness of DBS as a treatment for dementia, we performed DBS in a rat model of dementia
with intracerebroventricular administration of 192 IgG-saporins.We utilized four groups of rats, group 1, unlesioned control; group
2, cholinergic lesion; group 3, cholinergic lesion plus medial septum (MS) electrode implantation (sham stimulation); group 4,
cholinergic lesions plus MS electrode implantation and stimulation. During the probe test in the water maze, performance of
the lesion group decreased for measures of time spent and the number of swim crossings over the previous platform location.
Interestingly, the stimulation group showed an equivalent performance to the normal group on all measures. And these are
partially reversed by the electrode implantation. Acetylcholinesterase activity in the hippocampus was decreased in lesion and
implantation groups, whereas activity in the stimulation groupwas not different from the normal group.Hippocampal neurogenesis
was increased in the stimulation group. Our results revealed that DBS of MS restores spatial memory after damage to cholinergic
neurons. This effect is associated with an increase in hippocampal cholinergic activity and neurogenesis.
1. Introduction
It is widely accepted that brain function can be mod-
ulated by electrical stimulation of focal brain structures;
furthermore, that electrical stimulation may possibly be used
to treat patients with brain dysfunction. In particular, deep
brain stimulation (DBS) has been used to treat various
types of movement disorders and psychiatric disorders [1–
3]. Recently, DBS of memory-associated brain structures
were tested as a possible treatment for Alzheimer’s-type
dementia, with some studies providing promising results. For
example, some authors report that hypothalamic stimulation
modulates limbic activity and improves certain memory
functions [4], and others report that DBS of the nucleus
basalis magnocellularis (NBM) improves cognitive function-
ing in patients with Parkinson’s disease-related dementia [5].
Furthermore, stimulation of the entorhinal region was found
to enhance memory for spatial information when applied
during learning [6]. In animal studies, high frequency stim-
ulation activates specific amino acids in the hippocampus
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that may be involved in the enhancement of short-term
memory formation [7]. Also, formation of water maze mem-
ory is facilitated after bilateral stimulation of the entorhinal
cortex [8].
Clinical evidence obtained from patients with dementia
or other neurological disorders shows that DBS could be
used as a tool to enhance memory function. However,
this evidence is not strong, as the clinical trials were not
randomized and case-controlled or did not employ large
sample sizes. Therefore, disease-specific animal experiments
are necessary to advance the clinical application of DBS.
There are varied results due to the administration of 192 IgG-
saporin [9–14]. We made the experiment with a rat model of
dementia by intracerebroventricular (ICV) 192 IgG-saporin
injections. And we found that spatial memory is profoundly
impaired in this model [15]. Here, we used the 192 IgG-
saporin rat model of dementia to confirm the effects of DBS
on spatial memory function.
Degeneration of cholinergic basal forebrain neurons,
including the medial septum (MS), is a common feature
of Alzheimer’s disease and vascular dementia and has been
correlated with cognitive decline [16–19]. Projections from
the MS to the hippocampus consist of more than three
types of fibers, including cholinergic, GABAergic, and glu-
tamatergic fibers [20–22] and are the primary source of
cholinergic input to the hippocampus [23, 24]. Furthermore,
the MS is reported to regulate hippocampal activity through
acetylcholine, GABA, and glutamate [25–28].
DBS therapy for dementia has not yet established the
most effective stimulation site and parameter. In general, high
frequency stimulation leads to long term potentiation, and
low frequency stimulation induces long term depression [29].
However, recent reports showed that long term potentiation
could be induced by low frequency stimulation [30, 31].
Some studies evaluating the hippocampal effect by the MS
stimulation are mostly divided into low frequency (<10Hz)
or high frequency (>100Hz) stimulation [32–34]. Therefore,
we stimulated theMSwithmidfrequency (60Hz) stimulation
trains to evaluate the therapeutic potential of this frequency
range for reversing spatial memory impairments induced by
the loss of cholinergic neurons.
2. Materials and Methods
2.1. Animals. The present study was conducted according to
the guidelines for the care and use of laboratory animals of
the NATIONAL RESEARCH COUNCIL, USA. Rats were
housed one to three per cage in a temperature- and humidity-
controlled room, and all rats had free access to food andwater
with a 12-hour light/12-hour dark cycle.
Fifty male Sprague Dawley rats (200–250 g) were ran-
domly assigned to one of the following groups. Rats in the
normal (𝑛 = 11) group had no surgical procedure. Rats in
the lesion (𝑛 = 15) group had ICV administration of 192
IgG-saporin. Rats in the implantation (𝑛 = 14) group had
ICV administration of 192 IgG-saporin and implantation of
an electrode in theMS. Rats in the stimulation (𝑛 = 10) group
had ICV administration of 192 IgG-saporin and electrical
stimulation of the MS.
2.2. Surgical Procedure. Thirty-nine rats were anesthetized
with a mixture of ketamine (75mg/kg), acepromazine (0.75
mg/kg), and rompun (4mg/kg) and secured in a stereotaxic
frame. After scalp incision, rats were injected bilaterally with
8 𝜇L of 192 IgG-saporin (0.63 𝜇g/𝜇L, Chemion, Temecula,
CA) into ICV following coordinates relating to Bregma: AP:
−0.8mm, ML: ±1.2mm, and DV: −3.4mm. The solutions
were delivered at a rate of 1 𝜇L/min. The syringe was left in
place for 5min after injection.
After the administration of 192 IgG-saporin, 24 rats had
an additional procedure for electrode implantation. A hole
was drilled in the skull at the level of the MS, and a tungsten
electrode was implanted in the MS (AP + 0.6mm, ML
0.1mm, andDV−6mm).The stimulation electrode was fixed
with dental cement (Long Dental Manufacturing, Wheeling,
IL). This group was further divided into two groups, with 12
rats originally in the implantation group and 12 rats originally
in the simulation group. However, two rats in the stimulation
group were not stimulated due to a problem with the wire.
Therefore, the implantation group consisted of 14 rats, and the
stimulation group consisted of 10 rats.
2.3. Stimulation Electrode and Parameters. A tungsten stimu-
lation electrode (200 𝜇m diameter, 5 𝜇m parylene coating)
was inserted into the MS.The tip of electrode was tapered by
electrochemical etching to reduce damage to the target area
electrical stimulation consisted of pulses (120𝜇s duration,
50 𝜇A) delivered at 60Hz. Stimulation parameters weremon-
itored in real time at the beginning and end of stimulation
with an oscilloscope (HDS 1022M, Owon, Korea). Rats were
stimulated daily beginning a week after surgery until the end
of behavioral testing (5 consecutive hours per day, every day
for 2 weeks). Stimulation was delivered after the daily water
maze training session.
2.4. Behavioral Test: Morris Water Maze. Two weeks after
surgery, rats were trained in the Morris water maze as prev-
iously described [15]. Training consisted of four trials per day
for 5 days with the platform in a fixed position. For each
training trial, the rat was placed into the pool at one of four
semirandomly chosen starting points and given 60 s to reach
the platform. Any rat that did not reach the platform within
60 s was led to the platform by the experimenter and allowed
to remain on the platform for 10 s. After 48 hours from the
final training trial, the rats were given a probe trial lasting
60 s, during which the platform was removed from the pool.
Swim paths were recorded using a video tracking system.
During training trials, swim distance, latency to reach the
platform, and swim speed were measured. During the probe
trial, swimdistance, swim speed, swim time in each quadrant,
the time spent in the platform zone, and the number of
platform crossings were also measured.
2.5. Histological Evaluation. Immediately after behavioral
testing (probe test), 8 out of 11 rats from the normal group, 8
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out of 15 rats from the lesion group, 8 out of 14 rats from the
implantation group, and 6 out of 10 rats from the stimulation
group were anesthetized with a mixture of ketamine, acepro-
mazine, and rompun and perfused with normal saline and
cold 4% paraformaldehyde. Brains were removed, postfixed,
and transferred to 30% sucrose for 4 days. The brains were
sectioned into 30 𝜇m sections using a freezing microtome
and stored in a cryoprotectant solution (0.1M phosphate
buffer (pH 7.2), 30% sucrose, 1% polyvinylpyrrolidone, and
30% ethylene glycol) at −20∘C. Anatomical landmarks from
a stereotaxic atlas [35] were used to localize the MS and
hippocampus.
Floating sections were used to detect location of elec-
trode, cholinergic cells, and neurogenesis. Cresyl violet stain-
ing was performed to confirm the location of electrode.
To perform immunohistochemistry, sections were incubated
in 0.3% H
2
O
2
for 30min to inactivate endogenous perox-
idase activity. They were blocked with 5% normal serum
and incubated with polyclonal antibodies against choline
acetyltransferase (1 : 200, ChAT, Chemicon, Temecula, CA)
or doublecortin (1 : 200, Santa Cruz Biotechnology Inc., Santa
Cruz, CA) overnight at 4∘C.The sections were incubatedwith
biotinylated secondary antibodies, followed by the avidin-
biotin complexmethod (ABCElite, Vector Labs, Burlingame,
CA). They were visualized with diaminobenzidine (DAB)
using a DAB substrate kit (Thermo, Fremont, CA).
2.6. Acetylcholinesterase (AChE) Assay. The remaining rats (3
out of 11 rats from the normal group, 7 out of 15 rats from the
lesion group, 6 out of 14 rats from the implantation group, and
4 out of 10 rats from the stimulation group) were anesthetized
with a mixture of ketamine, acepromazine, and rompun
and decapitated with a guillotine. The brains were quickly
removed to acquire protein for AChE assay. TheMS and hip-
pocampus were dissected with fine forceps from 1mm coro-
nal brain slices.The samples were homogenized in lysis buffer
(Intron, Seongnam, Korea) and placed in ice for 30min. The
samples were centrifuged for 20min at 12,000 rpm, and the
protein in supernatant was measured using the bicinchoninic
acid protein assay reagent kit (Pierce, Rockford, IL). The
protein samples were stored at −70∘C.The enzymatic activity
of AChE was determined using the method of Ellman et al.
[36] with some modifications as previously described [15].
Briefly, 20 𝜇L triplicate samples were mixed with the reac-
tion mixture (0.2mM dithiobisnitrobenzoic acid (Sigma,
St. Louis, MO), 0.56mM acetylthiocholine iodide (Sigma,
St. Louis, MO), 10 𝜇M tetraisopropyl pyrophosphoramide
(Sigma, St. Louis, MO), and 39mM phosphate buffer, pH 7.2)
at 37∘C. After 30min, the optical density was measured at
405 nm.
2.7. Data Analysis. Indices of water maze probe test were
expressed as a percentage of the values of the normal
group. Doublecortin immunopositive cells were counted in
10 coronal sections per group, located 3.0 to 3.6mmposterior
to bregma. The number of doublecortin immunopositive
cells was presented as mean ± standard error of the mean
(SEM). One-way analysis of variance was used for overall
analysis of experiments except training trials, followed by a
least significant difference test or Tukey honestly significant
difference test as post hoc tests at each time point. 𝑃 values
less than 0.05 were considered statistically significant. Water
maze training trials were analysed with Linear Mixed Model.
Statistical analyses were performed using PASW (version 18;
SPSS Inc., Chicago, IL) and SAS version 9.2 (SAS Institute
Inc., Cary, NC, USA).
3. Results
3.1. Spatial Memory Testing. The results of water maze train-
ing are shown in Figure 1(a). The latencies of the first day
were decreased under the 20 seconds on the final day of
the training trails. From the first day to the fifth day, the
differences among the days were statistically significant (𝑃 <
0.0001) regardless of group.However, therewas no significant
difference among the groups depending on the time passage
(𝑃 = 0.3897). Taken together, these data show that latency
to reach the platform declined progressively across training
days for all groups, indicating progressive learning of the
hidden platform location. Water maze probe test indices
were expressed as a percentage of values for the normal
group (Figure 1(b)).The lesion, implantation, and stimulation
groups showed no differences from the normal group in
motor-related behavior, evidenced by similar swim distances
and speeds. These findings suggest no effect of cholinergic
lesion, electrode implantation, or electrical stimulation on
motor function. However, the amount of time that the lesion
group spent in the target quadrant was decreased to 70% of
normal group values. Also, the amount of time that the lesion
group spent in the platform zone was significantly decreased
to 26% of normal group values (𝑃 = 0.006), whereas it was
only decreased to 70% (𝑃 = 0.472) and 98% (𝑃 = 0.965) for
the implantation and stimulation groups, respectively. More-
over, the number of platform crossings was significantly
reduced to 27% (𝑃 < 0.001) and 61% (𝑃 = 0.039) for the
lesion and implantation groups, respectively, whereas it was
only decreased to 95% for the stimulation group (𝑃 = 0.805).
3.2. Histological Evaluations. The location of stimulating
electrodes in theMSwas confirmedwith cresyl violet staining
(Figure 2).
Intraventricular 192 IgG-saproin injections produced
denervation of ChAT immunopositive neurons in the MS,
which is thought to be part of the basal forebrain complex
(Figure 3). The ChAT immunopositive neurons in normal
rats were evenly distributed in the MS, and the structure of
the cell bodies and dendrites were wholly intact as shown in
Figure 3(a). In contrast, lesion, implantation, and stimulation
groups, which were injected with 192 IgG-saporin, showed
noticeable damage of cell body and dendrite structures.
We quantified the number of hippocampal cells con-
taining doublecortin, which is expressed in various neuro-
genesis stages from the differentiation phase to the axonal
and dendrite targeting phase, using immunohistochemistry
(Figure 4). The lesion group showed a significant decline in
numbers of doublecortin immunopositive cells to 77.6% of
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Figure 1: Effect of MS-DBS on spatial memory. Latency indicates the time required for the rat to find the escape platform during training
trails. During training trails, all groups gradually acquired the location of the platform (a). After a delay of two days, spatial memory was
improved by MS-DBS (b). Time spent in the platform zone (𝑃 < 0.05) and number of crossings (𝑃 < 0.005) was significantly different
between lesion and normal groups. However, the stimulation group did not differ from the normal group. There was no disruption of motor
function in any group. Data are shown as mean ± SEM (a). Indices are expressed as the percentage of normal group values (b). MS: medial
septum; DBS: deep brain stimulation: Dist: distance.
MS
Figure 2: Cresyl violet stained coronal section and slide of atlas [35] at MS level. Arrow heads show the tract of the electrode in the MS.
normal group values (𝑃 = 0.002), which confirms the effect
of damaged basal forebrain cholinergic neuron on hip-
pocampal neurogenesis. The implantation group did not
show a significant difference from the lesion group (𝑃 =
0.142). However, the stimulation group showed a significant
increase in the number of doublecortin immunopositive cells
compared with the lesion group (𝑃 = 0.002).
3.3. AChE Assay. In the medial prefrontal cortex, AChE
activity was declined in the lesion and implantation groups
(Figure 5), although there were no statistically significant
differences from the normal group. AChE activity in the
stimulation group was higher than that in the normal group,
and it was more significantly increased than that in the
implantation group (𝑃 = 0.028). There was a statistically
significant decline in hippocampalAChE activity in the lesion
group (𝑃 = 0.045) and implantation group (𝑃 = 0.001) com-
pared with the normal group. Interestingly, hippocampal
AChE activity in the stimulation group was similar to that
in the normal group and it is more significantly increased
than that in the lesion (𝑃 = 0.038) and implantation groups
(𝑃 = 0.001).
4. Discussion
Because medications for dementia have limitations, such as
side effects or temporary efficacy, the study of alternative
therapies is needed. DBS has been approved by the US Food
and Drug Administration and can safely be used for move-
ment disorders like Parkinson’s disease or tremor. Recently,
BioMed Research International 5
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Figure 3: Representative pictures showing the effects of the cholinergic lesion on the basal forebrain.The normal group had numerous ChAT
immunopositive neurons in the MS (a). The lesion (b), implantation (c), and stimulation (d) groups displayed a loss of cholinergic neurons
in the MS. Scale bar represents 500 𝜇m. ChAT: choline acetyltransferase; MS: medial septum.
the possibility that DBS can enhance memory function has
been reported in some clinical cases and experimental studies
[4–8]. However, the mechanisms of DBS are unclear, and
effective stimulation parameters, such as duration and loca-
tion, are still not well defined.Therefore, experimental studies
are needed.
Longer durations of MS-DBS might provide greater
therapeutic effects than shorter durations of stimulation.
Therefore, we stimulated the MS starting 1 week before the
behavioral test and continued stimulating until the end of
the test. Laxton et al. [37] reported possible improvements
in cognition and slowing of the rate of cognitive decline
by continuous fornix/hypothalamus DBS for 12 months.
Compared to baseline, an increase in brainmetabolism in the
temporal and parietal cortical regions was observed 1 month
after DBS and was sustained for 12 months. We confirmed
that motor function was unaltered in the stimulation group,
which received electrical stimulation for 2 weeks.
Although we do not know which stage of memory pro-
cessing was affected by MS-DBS, long term spatial memory
was improved. An interesting finding in this study was that
the impairment in spatial memory by 192 IgG-saporin was
rescued by MS-DBS. Therefore, we propose that 60Hz MS-
DBS has positive effects on spatial memory.
It has been reported that ICV injection of 192 IgG-
saporin damaged both cholinergic basal forebrain neurons
and Purkinje cell in the cerebellum [38]. Also, Cerebellar
Purkinje cell loss in AD patients has been reported. Because
of the similarity in the loss of Purkinje cell [39, 40], using of
192 IgG-saporin is not a big problem for making a dementia
model. When 192 IgG-saporin is injected into the ICV rather
than direct administration in MS, cholinergic cells have
higher survival rate. In this study, we administrated 192 IgG-
saporin into the ICV. And averagely 35% of the cholinergic
cells were intact in the MS. Our finding of residual ChAT
immunopositive cells and AChE activity indicates that basal
forebrain cholinergic neurons were not completely damaged
by administration of intraventricular 192 IgG-saporin. We
believe that MS-DBS influenced the activity of the hip-
pocampus via projections from the MS through remaining
cholinergic neurons despite injection of 192 IgG-saporin.
A single shock or brief tetanic stimulation of the MS
was found to sharply enhance population spikes evoked in
the hippocampal CA1 pyramidal cell layer, and a comparable
facilitation of population spikes was produced bymicroappli-
cation of acetylcholine at the same site [41]. Both cholinergic
and GABAergic mechanisms have been proposed to explain
this effect.MS facilitation of hippocampal activity ismediated
by inhibition of inhibitory interneurons [42]. Cholinergic-
and GABAergic-mediated septal drive plays a role in the
tuning of signal conversion within the hippocampus [43].
Low-frequency stimulation of the MS and commissural
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Figure 4: Effects of MS-DBS on adult hippocampal neurogenesis revealed by doublecortin immunohistochemistry. Representative pictures
show the effects of basal forebrain cholinergic deficits andMS-DBS on hippocampal neurogenesis (a–d). Many doublecortin immunopositive
cells were observed in the normal group (a). However, the number of these cells was decreased in the lesion (b) and implantation (c) groups,
in which basal forebrain cholinergic neurons were damaged, but not in the stimulation group (d). After counting the immunopositive cells
(e), we found that the number of cells in the normal group was significantly different from that in the lesion group (𝑃 < 0.05). However, there
was no difference between the lesion group and the implantation group, which was only implanted with an electrode in the MS.The number
of doublecortin immunopositive cells was significantly increased in the stimulation group (𝑃 < 0.05), which had damaged basal forebrain
cholinergic neurons and received electrical stimulation of the MS.
fibers induces NMDA-dependent, long-lasting potentiation
of hippocampal synapses [30]. Electrical stimulation of the
MS could possibly affect these systems, although we did
not investigate GABAergic or glutamatergic changes in this
study. Moreover, the increase in hippocampal acetylcholine
by MS-DBS could affect hippocampal theta rhythm and
spatial memory. Considerable research has demonstrated
correlations between hippocampal theta rhythm and learning
and memory [44–46], and positive correlations between
hippocampal acetylcholine and theta rhythm have also been
reported [47–49].
The other potential mechanism through which MS-
DBS could enhance spatial memory is via hippocampal
neurogenesis. Adult hippocampal neurogenesis is restricted
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Figure 5: Effect of MS-DBS on AChE activity. In the prefrontal
cortex, AChE activity of the stimulation group was significantly
increased more than that in implantation group (𝑃 < 0.05).
Hippocampal AChE activity in the lesion (𝑃 < 0.05) and implan-
tation (𝑃 < 0.005) groups was significantly less than that in the
normal group. However, AChE activity in the stimulation group
was equivalent to that in the normal group. The AChE activity
was expressed as the optical density of the colorimetric reading at
405 nm. Values are mean ± SEM. OD: optical density.
to the subgranular zone of the dentate gyrus (DG), and new
neurons continue to be generated throughout the lifespan.
Hippocampal neurogenesis is thought to be associated with
hippocampus-dependent memory. Knockdown of adult hip-
pocampal neurogenesis impairs spatial memory [50], and
treatments that disrupt hippocampal neurogenesis impair
hippocampus-dependent memory [51, 52]. Adult hippocam-
pal neurogenesis is thought to consist of several develop-
mental processes [53]. Doublecortin (DCX) is a protein that
promotes microtubule polymerization and can serve as a
marker of adult neurogenesis during the stages of late mitotic
neuronal precursors and early postmitotic neurons [54, 55].
DCX is expressed specifically in newly generated neurons.
DCX is not expressed in GFPA-expressing astrocytes. Also
the study shows absence of DCX expression during neu-
ronal regeneration or lesion induced gliogenesis [56]. We
confirmed that a deficiency of basal forebrain cholinergic
neurons reduces the number of DCX immunopositive cells
in the subgranular zone of the DG. This result supports
previous findings that damage of basal forebrain cholinergic
neurons decreases neurogenesis in the granule cell layer of
the DG and increases the number of apoptotic cells [57–59].
Interestingly, Stone et al. reported that electrical stimulation
of the entorhinal cortex promotes proliferation in theDG and
the integration of these neurons into hippocampal circuits
supporting spatial memory [8]. In this study, stimulation
of the MS after cholinergic damage recovers the number of
DCX immunopositive cells, suggesting that MS-DBS pro-
motes neurogenesis in the DG, which, in turn, may promote
hippocampus-dependent learning and memory. We specu-
late that MS-DBS may increase hippocampal acetylcholine
and thereby promote hippocampal neurogenesis. Cholinergic
activation increases proliferation of hippocampal neural stem
cells and enhances the survival of newborn neurons [60, 61].
Unexpectedly, the behavioral test deficits of lesioned rats
seen during the probe trials appear to be partially reversed by
the electrode implantation, even in the absence of electrical
stimulation. Insertion effect is common phenomenon after
deep brain stimulation surgery for Parkinson disease or
neuropathic pain patients [62, 63]. After the insertion of elec-
trode into the subthalamic nucleus for PD patients, glucose
metabolism has been changed in the absence of stimulation
[64]. In the unstimulated hippocampus, enzyme activity is
changed in the narrow area surrounding the electrode [65]. In
animal study, it has been reported that the different thickness
of electrode induced a various regional neuroinflammation
and recognition deficits [66]. This different effect on mem-
ory from our results could be caused by the thickness of
used electrode (280, 150 𝜇m versus 200𝜇m) and the site of
implantation (subthalamic nucleus versus MS). Because the
insertional effects are still unclear, the relevant studies are
needed in the future.
In conclusion, we found that MS-DBS increases hip-
pocampal acetylcholine and neurogenesis and restore spatial
memory from cholinergic malfunction due to basal forebrain
cholinergic deficiency. Although we do not knowwhich stage
of memory processing is affected by MS-DBS, our study is
important in that it confirms the therapeutic effect of MS-
DBS.
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